Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke

NCT00790920 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: Desmoteplase
DRUG: Placebo

Sponsor

H. Lundbeck A/S